ACURX PHARMACEUTICALS INC

Historical 13F Holders

Reported Value, Excluding Options

Total Filings

Investors who own more than 5% of a class must file a Schedule 13D or 13G. Each filer's latest filing for 00510M203 since 12/18/2024, largest first.

Filer	% of Class	Shares	Form	Filed
Under 5%, checked the "5 percent or less" box, or amended by a later filing (1)
Armistice Capital, LLC 13G/A Amended under CUSIP 231269309 on 2/17/2026	10.0%	1,287,337	13G/A	8/14/2025 Event 6/30/2025
Armistice Capital, LLC	10.0%	1,287,337
Steven Boyd	10.0%	1,287,337

Period	Filings	Shares, Excl. Options	Value, Excl. Options	Options Value
2026 Q2	19	120 k	$185 k	$0
2026 Q1	21	182 k	$674 k	$0
2025 Q4	18	139 k	$345 k	$0
2025 Q3	16	55.8 k	$244 k	$0
2025 Q2	1	167	$850.00	$0